Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 4,152 |
|
|||||
| News | - | ||||||
| Day High | 16.08 | Low High |
|||||
| Day Low | 16.08 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc | EYPT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.08 | -0.50% | 16.08 | 09:30:14 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 16.08 | 16.08 | 16.08 | 16.16 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15 | 4,152 | $ 16.08 | $ 66,764 | - | 5.67 - 30.99 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:30:24 | 1 | $ 16.05 | USD |
EyePoint Pharmaceuticals (EYPT) Options Flow Summary
EyePoint Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 805.27M | 49.83M | - | 46.02M | -70.8M | -1.42 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
EyePoint Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EYPT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.67 | 18.68 | 15.51 | 17.04 | 1,159,000 | -1.59 | -9.00% |
| 1 Month | 20.60 | 23.645 | 15.51 | 18.89 | 902,254 | -4.52 | -21.94% |
| 3 Months | 28.49 | 30.99 | 15.51 | 23.71 | 984,690 | -12.41 | -43.56% |
| 6 Months | 6.34 | 30.99 | 5.67 | 20.20 | 1,258,813 | 9.74 | 153.63% |
| 1 Year | 6.99 | 30.99 | 5.67 | 16.84 | 907,069 | 9.09 | 130.04% |
| 3 Years | 9.74 | 30.99 | 2.19 | 14.07 | 511,263 | 6.34 | 65.09% |
| 5 Years | 1.74 | 30.99 | 0.3511 | 7.57 | 639,131 | 14.34 | 824.14% |
EyePoint Pharmaceuticals Description
| EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome Technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. |
